Ex Parte NIJKERK et al - Page 2



             Appeal No. 2001-1162                                                           Page 2               
             Application No. 08/726,803                                                                          
                   (ii)     a stabilizer selected from the group consisting of sodium citrate, sodium            
                   acetate, and mixtures thereof,                                                                
                   (iii)    optionally, an isotonizing agent, and                                                
                   (iv)     optionally, a buffer selected from the group consisting of tris, phosphate           
             and carbonate buffers.                                                                              
                   11.  An aqueous folinate solution of sodium salts for pharmaceutical applications,            
             consisting of                                                                                       
                   sodium folinate in a concentration of about 15 to 400 mg folinic acid per ml,                 
                   a stabilizer selected from the group consisting of sodium citrate, sodium acetate,            
             and mixtures thereof,                                                                               
                   optionally, an isotonizing agent,                                                             
                   optionally, a buffer selected from the group consisting of tris, phosphate and                
             carbonate buffers, and optionally, a pH adjusting agent.                                            
                   The references relied upon by the examiner are:                                               
             Mueller et al. (Mueller)         5,134,235           Jul.   28, 1992                                
             Haeger                           5,173,488           Dec. 22, 1992                                  
             Eur. Pat. App. (Buchs)           0 667 159 A2        Aug. 16, 19951                                 
                                                                                                                
             Hoover, Remington's Pharmaceutical Sciences (Remington's), 15th edition, pp. 268-270                
             and 283-284 (Easton, Pa; Mack Pub. Co. 1975)                                                        
             Hagers Handbook (Hagers), 4th edition, Vol. 7, P+. A, page 368 (1971)                               

                   Claims 2 and 5 through 17 stand rejected under 35 U.S.C. § 103(a).  As                        
             evidence of obviousness, the examiner relies upon Haeger, Buchs, Mueller,                           
             Remington's, and Hagers.  We reverse.                                                               


                                                   Discussion                                                    

                   1   The examiner's rejection as stated in the Examiner's Answer is based upon                 
             the English abstract provided in this German language document.  However, in                        
             response to a remand from the board, the examiner obtained a full-text translation of               
             Buchs.  Our consideration of the issues raised in this appeal is based upon the full text           
             translation.                                                                                        





Page:  Previous  1  2  3  4  5  6  7  8  Next 

Last modified: November 3, 2007